India Develops 4% of global antibacterial Agents.
Science and Technology
The number of antibacterial agents in the clinical pipeline, including antibiotics, increased globally from 80 in 2021 to 97 in 2023, according to the World Health Organization, India has 4% of the total percentage of antibacterial agents in clinical development by location of research facilities, according to the report on antibacterial agents in clinical and preclinical development worldwide. Among the upper middle-income countries, China, Russia and South Africa comprised 7%, 3%, and 2% of the agents, respectively, and 84% put together from the pipeline was in the high-income countries.
First released in 2017, this WHO annual report evaluates whether the current R&D pipeline properly addresses infections caused by drug-resistant bacteria most threatening to human health.
The aim is to steer antibacterial research and development to better counter the ever-growing threat of antimicrobial resistance (AMR).
Director-General - Tedros Adhanom Ghebreyesus
Headquarters - Geneva, Switzerland
____________________________
